Author:
Dasí Francisco,Lledó Salvador,García-Granero Eduardo,Ripoll Roberto,Marugán Maribel,Tormo Mar,García-Conde Javier,Aliño Salvador F
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Pathology and Forensic Medicine
Reference9 articles.
1. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, and Wright WE (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349–352.
2. Chen XQ, Bonnefoi H, Pelte M-F, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M, and Anker P (2000). Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6: 3823–3826.
3. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, and DePinho RA (1999). p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere disfunction to accelerate carcinogenesis. Cell 97: 527–538.
4. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, and Bacchetti S (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921–1929.
5. de Kok JB, Zendman AJ, van de Locht LT, Ruers TJ, van Muijen GN, Mensink EJ, and Swinkels DW (1999). Real-time hTERT quantification: A promising telomerase-associated tumor marker. Lab Invest 79: 911–912.
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献